Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (180)
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
36,347
Price
$1.89
Total Value
$68.76K
Shares Held After
2,944,354
% of Holdings
1.2%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
23,485
Price
$1.95
Total Value
$45.69K
Shares Held After
2,908,007
% of Holdings
0.8%
QTREX Quantum Ltd. (QTEX)
Parnes Tal — Director
Shares
6,666
Price
$1.50
Total Value
$10.00K
Shares Held After
766,666
% of Holdings
0.9%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
984
Price
$1.32
Total Value
$1.30K
Shares Held After
955,493
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,233
Price
$1.93
Total Value
$21.73K
Shares Held After
2,884,522
% of Holdings
0.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
170,000
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,451
Price
$85.00
Total Value
$208.33K
Shares Held After
169,900
% of Holdings
1.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,449
Price
$84.07
Total Value
$205.89K
Shares Held After
167,449
% of Holdings
1.5%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
745,588
% of Holdings
0.0%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$85.00
Total Value
$209.95K
Shares Held After
745,488
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$84.07
Total Value
$207.65K
Shares Held After
743,018
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
10,000
Price
$8.46
Total Value
$84.57K
Shares Held After
1,037,000
% of Holdings
1.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,021
Price
$1.33
Total Value
$10.67K
Shares Held After
954,509
% of Holdings
0.8%
QTREX Quantum Ltd. (QTEX)
Ben-Noon Dagi Shahar — Director
Shares
14,093
Price
$1.49
Total Value
$21.00K
Shares Held After
14,093
% of Holdings
100.0%
Beyond Air, Inc. (XAIR)
Lin Yi-Chien — 10% Owner
Shares
2,607
Price
$2.21
Total Value
$5.76K
Shares Held After
148,000
% of Holdings
1.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.35
Total Value
$835.48K
Shares Held After
1,027,000
% of Holdings
9.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
564
Price
$1.33
Total Value
$750.12
Shares Held After
946,488
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
7,215
Price
$2.02
Total Value
$14.57K
Shares Held After
2,873,289
% of Holdings
0.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,340
Price
$2.04
Total Value
$10.92K
Shares Held After
2,866,074
% of Holdings
0.2%
NEOGEN CORP (NEOG)
Nassif Mikheal — Director
Shares
505
Price
$11.95
Total Value
$6.03K
Shares Held After
1,579
% of Holdings
32.0%
QTREX Quantum Ltd. (QTEX)
Ben-Noon Dagi Shahar — Director
Shares
18,181
Price
$1.67
Total Value
$30.36K
Shares Held After
3,664,314
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
2,077
Price
$2.02
Total Value
$4.19K
Shares Held After
2,860,734
% of Holdings
0.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
90,000
Price
$8.57
Total Value
$770.90K
Shares Held After
529,000
% of Holdings
17.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
2,256
Price
$1.33
Total Value
$3.00K
Shares Held After
945,924
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
268
Price
$4.84
Total Value
$1.30K
Shares Held After
227,604
% of Holdings
0.1%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
328
Price
$4.84
Total Value
$1.59K
Shares Held After
199,673
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
1,937
Price
$4.84
Total Value
$9.38K
Shares Held After
9,530
% of Holdings
20.3%
SkyAI, Inc. (SKYA)
Bastion Trading Ltd — 10% Owner
Shares
44,000
Price
$1.78
Total Value
$78.26K
Shares Held After
1,429,417
% of Holdings
3.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
125,000
Price
$8.40
Total Value
$1.05M
Shares Held After
439,000
% of Holdings
28.5%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,046
Price
$1.33
Total Value
$4.05K
Shares Held After
943,668
% of Holdings
0.3%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
272,695
Price
$7.18
Total Value
$1.96M
Shares Held After
6,358,271
% of Holdings
4.3%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,601
Price
$1.33
Total Value
$7.44K
Shares Held After
940,622
% of Holdings
0.6%
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. — Director
Shares
3,700
Price
$0.06
Total Value
$203.50
Shares Held After
9,433,656
% of Holdings
0.0%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
648,455
Price
$7.51
Total Value
$4.87M
Shares Held After
12,778,380
% of Holdings
5.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
27,000
% of Holdings
9.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.57
Total Value
$857.24K
Shares Held After
314,000
% of Holdings
31.8%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
236,354
Price
$7.78
Total Value
$1.84M
Shares Held After
12,129,925
% of Holdings
1.9%
Outset Medical, Inc. (OM)
Leonard Braden Michael — 10% Owner
Shares
16,575
Price
$3.88
Total Value
$64.24K
Shares Held After
2,764,610
% of Holdings
0.6%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
20,000
Price
$2.07
Total Value
$41.37K
Shares Held After
2,856,963
% of Holdings
0.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
Outset Medical, Inc. (OM)
Leonard Braden Michael — 10% Owner
Shares
228,334
Price
$3.53
Total Value
$806.02K
Shares Held After
2,748,035
% of Holdings
8.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
38,796
Price
$2.04
Total Value
$78.96K
Shares Held After
2,836,963
% of Holdings
1.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
16,431
Price
$1.33
Total Value
$21.85K
Shares Held After
908,532
% of Holdings
1.8%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.42
Total Value
$14.20K
Shares Held After
1,580,294
% of Holdings
0.6%
Beyond Air, Inc. (XAIR)
Lin Yi-Chien — 10% Owner
Shares
15,393
Price
$2.80
Total Value
$43.10K
Shares Held After
145,393
% of Holdings
10.6%
Compass Therapeutics, Inc. (CMPX)
Lerner Neil — Chief Accounting Officer
Shares
20,000
Price
$0.92
Total Value
$18.40K
Shares Held After
420,000
% of Holdings
4.8%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
322,940
Price
$7.60
Total Value
$2.45M
Shares Held After
5,200,767
% of Holdings
6.2%
180 transactions